Bio-Pharm Must Face Generic-Drug Supply Contract Suit
Bio-Pharm Inc. must face a suit accusing the company of reneging on a drug supply agreement and holding generic medication "hostage" in order to gain a larger share of the profits...To view the full article, register now.
Already a subscriber? Click here to view full article